Brief: Gentian Diagnostics Q2 Sales Of NOK 43.6 Mln
10/07/2025 07:38
July 10 (Reuters) - Gentian Diagnostics ASA GENT.OL: SALES OF NOK 43.6 MILLION IN 2Q25, UP 14% VERSUS 2Q24 EBITDA OF NOK 1.7 MILLION IN 2Q25 VERSUS NOK 6.8 MILLION IN 2Q24 Source text: ID:nObi0cdMya Further company coverage: GENT.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company